100 likes | 110 Vues
Global liquid biopsy market size, share, market intelligence, company profiles, market trends, growth, potential, segmentation, research and analysis report, forecast 2018-2023
E N D
Orion Market Research Global Liquid Biopsy Market Research and Forecast, 2018-2023
DEFINITION A liquid biopsy is a non-invasive alternative to surgical biopsies used for discovering various information about a tumour through a simple blood sample. The rising prevalence of cancer diseases, high investment in R&D and growing preference for minimally invasive technology over alternate invasive methods are the driving factors of the liquid biopsy market.
MARKET MOTIVATORS • High prevalence of cancer diseases globally • Preference of minimally invasive method over alternate invasive method • Rising investment and funding for liquid biopsy along with increasing R&D • Collaboration between companies and public organization
MARKET SEGMENTATION • BY BIOMARKER TYPE • Circulating tumor cells • Circulating tumor DNA (ctDNA) • Others (extracellular vesicles)
MARKET SEGMENTATION • BY END-USER • Hospitals and laboratories • Academic and research centers
MARKET PLAYERS • Bio-Rad Laboratories Inc. • Hoffmann-La Roche Ltd. • Biodesix Inc. • QIAGEN NV • Thermo Fisher Scientific Inc.
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 305-308, Commerce House, Janjeerwala Square Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/liquid-biopsy-market/